The immune function of MHC class II molecules mutated in the putative superdimer interface



Analysis of the crystal structure of human class II (HLA-DR1) molecules suggests that the αβ heterodimer may be further ordered as a dimer of heterodimers (superdimer), leading to the hypothesis that T cell receptor dimerisation is a mechanism for initiating signaling events preceding T cell activation. The interface between pairs of molecules is stabilised by both salt bridges, polar and hydrophobic interactions. The residues that form the superdimer interface occur in three areas distinct from the antigen-binding groove. They can be defined as follows: region 1, β-β contacts in the helix of the β1 domain; region 2, α-α contacts near the α1/α2 domain junction and region 3; α-β contacts in the α2/β2 domains adjacent to the plasma membrane. To determine whether salt bridges and polar interactions formed within these regions are involved in the immune function of the murine MHC class II molecule, I-Ab, appropriate residues in both the α and β chain were identified and mutated to uncharged alanine. Cell lines transfected with different combinations of mutated α and β chains were generated and tested for MHC class II expression, peptide binding capabilities, and ability to present antigenic peptide to an OVA-specific T cell hybridoma. With the exception of two residues in region 2, the substitutions tested did not modulate MHC class II expression, or peptide binding function. When tested for ability to present peptide to an antigen-specific T cell hybridoma, with the exception of mutations in region 2, the substitutions did not appear to abrogate the ability of I-Ab to stimulate the T cells. These results suggest that mutation of residues in region 2 of the putative superdimer interface have a gross effect on the ability of I-Ab to be expressed on the cell surface. However, abrogation of salt bridges in region 1 and 3 do not influence I-Ab cell surface expression, peptide binding or ability to stimulate antigen-specific T cells.


MHC class II mutagenesis peptide binding superdimer T cell recognition 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15: 821–850, 1997CrossRefPubMedGoogle Scholar
  2. 2.
    Robinson JH, Delvig, AA: Diversity in MHC class II antigen presentation. Immunology 105: 252–262, 2002CrossRefPubMedGoogle Scholar
  3. 3.
    Roche PA, Marks MS, Cresswell P: Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354: 392–394, 1991CrossRefPubMedGoogle Scholar
  4. 4.
    Pieters J, Bakke O, Dobberstein B: The MHC class II-associated invariant chain contains two endocytic targetting signals within in its cytoplasmic tail. J Cell Sci 106: 831–842, 1993PubMedGoogle Scholar
  5. 5.
    Odorizzi CG, Trowbridge IS, Xue L, Hopkins CR, Davis CD, Collawn JF: Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to the endocytoplasmic processing compartment. J Cell Biol 126: 317–330, 1994CrossRefPubMedGoogle Scholar
  6. 6.
    Amigorena S, Drake JR, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369: 113–120, 1994CrossRefPubMedGoogle Scholar
  7. 7.
    Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I: Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 181: 1729–1741, 1995CrossRefPubMedGoogle Scholar
  8. 8.
    Denzin LK, Cresswell P: HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82: 155–165, 1995CrossRefPubMedGoogle Scholar
  9. 9.
    Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 509–512, 1987Google Scholar
  10. 10.
    Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39, 1993CrossRefPubMedGoogle Scholar
  11. 11.
    Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature 384: 134–141, 1996CrossRefPubMedGoogle Scholar
  12. 12.
    Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: An alpha-beta T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex. Science 274: 209–219, 1996CrossRefPubMedGoogle Scholar
  13. 13.
    Reinherz EL, Tan K, Tang L, Kern P, Liu JH, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, Joachimiak A, Chang HS, Wagner G, Wang JH: The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286: 1913–1921, 1999CrossRefPubMedGoogle Scholar
  14. 14.
    Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHCprotein HLA-DR1complexed withan influenza virus peptide. Nature 368: 215–221, 1994CrossRefPubMedGoogle Scholar
  15. 15.
    Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi Y, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711–718, 1994CrossRefPubMedGoogle Scholar
  16. 16.
    Kim J, Urban RG, Strominger JL, Wiley DC: Toxic shock syndrome toxin-1 complexed with class II histocompatibility molecule HLA-DR1. Science 266: 1870, 1994PubMedGoogle Scholar
  17. 17.
    Brown JH, Jardetzky TS, Stern LJ, Gorga JC, Strominger JL, Wiley DC: Human class II molecule HLA-DR1: X-ray structure determined from three crystal forms. Acta Cryst D51: 946–961, 1995Google Scholar
  18. 18.
    Fremont DH, Hendrickson WA, Marrack P, Kappler J: Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001–1004, 1996PubMedGoogle Scholar
  19. 19.
    Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA: Crystal structure of the Vα domain of a T cell antigen receptor. Science 270: 1821–1824, 1995PubMedGoogle Scholar
  20. 20.
    Schafer PH, Pierce SK: Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1: 699–707, 1994CrossRefPubMedGoogle Scholar
  21. 21.
    Roucard C, Garban F, Mooney NA, Charron DJ, Ericson ML: Conformation of human leukocyte antigen class II molecules: Evidence for superdimers and empty molecules on human antigen presenting cells. J Biol Chem 271: 13993–14000, 1996CrossRefPubMedGoogle Scholar
  22. 22.
    Hitzel C, Gruneberg U, van Ham M, Trowsdale J, Koch N: Sodium dodecyl sulphate-resistant HLA-DR “superdimer” bands are in some cases class II heterodimers bound to antibody. J Immunol 162: 4671–4676, 1999PubMedGoogle Scholar
  23. 23.
    Cherry RJ, Wilson KM, Triantafilou K, O’Toole P, Morrison IEG, Smith PR, Fernandez N: Detection of dimers of dimers of human leukocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J Cell Biol 140: 71–79, 1998CrossRefPubMedGoogle Scholar
  24. 24.
    Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel EJ, Davis MM: Ligand-specific oligomerisation of T cell receptor molecules. Nature 387: 617–620, 1997CrossRefPubMedGoogle Scholar
  25. 25.
    Lake RL, Robinson BWS, Hayball JD: MHC multimerisation, antigen expression and the induction of APC amnesia in the developing immune response. Immunol Cell Biol 77: 99–104, 1999CrossRefPubMedGoogle Scholar
  26. 26.
    Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JR: Effects of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 147: 1292–1298, 1991PubMedGoogle Scholar
  27. 27.
    Hewitt CR, Lamb JR, Hayball J, Hill M, Owen MJ, O’Hehir RE: Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med 175: 1493–1499, 1992CrossRefPubMedGoogle Scholar
  28. 28.
    Mizushima S, Nagata S: pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18: 5322, 1990PubMedGoogle Scholar
  29. 29.
    Hayball JD, Jones CM, Lamb JR, Lake RA: A T cell clone with three potential TCR alpha chain rearragements expresses only one receptor combinantion at the cell surface. Mol Immunol 33: 1177–1181, 1996CrossRefPubMedGoogle Scholar
  30. 30.
    Morgenstern JP, Land H: A series of mammalian expression vectors and characterisation of their expression of reporter gene in stably and transiently transfected cells. Nucleic Acids Res 18: 1068, 1990PubMedGoogle Scholar
  31. 31.
    Janeway CA, Conrad PJ, Lerner EA, Babich J, Wettstein P, Murphy DB: Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: Possible role of T cell bound Ia antigenis as targets of immunoregulatory T cells. J Immunol 132: 662–667, 1984PubMedGoogle Scholar
  32. 32.
    Bhattacharya A, Dorf ME, Springer TA: A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: Evidence for I region gene duplication. J Immunol 127: 2488–2495, 1981PubMedGoogle Scholar
  33. 33.
    Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, Braunstein NS, Hackett CJ, Rudensky A: A study of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur J Immunol 26: 385–393, 1996PubMedGoogle Scholar
  34. 34.
    Kristensen NM, Hoyne G, Hayball JD, Hetzel C, Bourne T, Lamb JR: Induction of T cell responses to the invariant chain derived CLIP peptide in mice immunised with the group 1 allergen of house dust mite. Int Immunol 8: 1091–1098, 1996PubMedGoogle Scholar
  35. 35.
    Heldin CH: Dimerisation of cell surface receptors in signal transduction. Cell 80: 203–223, 1995CrossRefGoogle Scholar
  36. 36.
    Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212, 1990CrossRefPubMedGoogle Scholar
  37. 37.
    Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76: 263–274, 1994CrossRefPubMedGoogle Scholar
  38. 38.
    Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353: 134–139, 1991CrossRefPubMedGoogle Scholar
  39. 39.
    Goodman S, Sawada T, Barbosa JA, Cole B, Pergolizzi R, Silver J, Mellines E, Chang MY: Mutational analysisof two DRα residues involved in dimers of HLA-DR molecules. J Immunol 155: 1210–1217, 1995PubMedGoogle Scholar
  40. 40.
    Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN: MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370: 647–650, 1994CrossRefPubMedGoogle Scholar
  41. 41.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY: Variation in HLA-DM expression influences conversion of MHC class II αβ:class II-associated invariant chain peptide complexes to mature peptide-bound class II αβ dimers in a normal B cell line. J Immunol 156: 2196–1204, 1996PubMedGoogle Scholar
  42. 42.
    Dianzani U, Shaw A, al Ramadi B, Kubo RT, Janeway CJ: Physical association of CD4 with the T cell receptor. J Immunol 148: 678–688, 1992PubMedGoogle Scholar
  43. 43.
    Kupfer A, Singer SJ, Janeway CJ, Swain SL: Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of the helper T cells and antigen presenting cells. Proc Natl Acad Sci 84: 5888–5892, 1987PubMedGoogle Scholar
  44. 44.
    Veillette A, Bookman MA, Horak EM, Bolen JB: The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine kinase p56lck. Cell 55: 301–308, 1988CrossRefPubMedGoogle Scholar
  45. 45.
    Cammarota G, Scheirle A, Takacs B, Doran DM, Knorr R, Bannwarth W, Guardiola J, Sinigaglia F: Identification of a CD4 binding site on the b2 domain of HLA-DR molecules. Nature 356: 799–801, 1992CrossRefPubMedGoogle Scholar
  46. 46.
    Konig R, Huang LY, Germain RN: MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356: 796–798, 1992CrossRefPubMedGoogle Scholar
  47. 47.
    Konig R, Shen X, Germain RN: Involvement of both major histocompatibility complex class II a and b chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med 182: 779–787, 1995CrossRefPubMedGoogle Scholar
  48. 48.
    Hampl J, Chien YH, Davis MM: CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7: 379–385, 1997CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia
  2. 2.Dame Roma Mitchell Cancer Research LaboratoriesHanson InstituteAdelaideAustralia
  3. 3.Queen Elizabeth II Medical SchoolUniversity Department of MedicinePerthAustralia
  4. 4.School of Pharmacy and Medical SciencesUniversity of South AustraliaAdelaideAustralia

Personalised recommendations